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Abstract 
The aim of this study was to investigate the correspondence of different biological ageing estimates (i.e. epigenetic 
age) in blood and muscle tissue and their associations with physical activity (PA), physical function and body com-
position. Two independent cohorts (N = 139 and N = 47) were included, whose age span covered adulthood (23–
69 years). Whole blood and m. vastus lateralis samples were collected, and DNA methylation was analysed. Four differ-
ent DNA methylation age (DNAmAge) estimates were calculated using genome-wide methylation data and publicly 
available online tools. A novel muscle-specific methylation age was estimated using the R-package ‘MEAT’. PA was 
measured with questionnaires and accelerometers. Several tests were conducted to estimate cardiorespiratory fitness 
and muscle strength. Body composition was estimated by dual-energy X-ray absorptiometry. DNAmAge estimates 
from blood and muscle were highly correlated with chronological age, but different age acceleration estimates were 
weakly associated with each other. The monozygotic twin within-pair similarity of ageing pace was higher in blood 
(r = 0.617–0.824) than in muscle (r = 0.523–0.585). Associations of age acceleration estimates with PA, physical func-
tion and body composition were weak in both tissues and mostly explained by smoking and sex. The muscle-specific 
epigenetic clock MEAT was developed to predict chronological age, which may explain why it did not associate with 
functional phenotypes. The Horvath’s clock and GrimAge were weakly associated with PA and related phenotypes, 
suggesting that higher PA would be linked to accelerated biological ageing in muscle. This may, however, be more 
reflective of the low capacity of epigenetic clock algorithms to measure functional muscle ageing than of actual age 
acceleration. Based on our results, the investigated epigenetic clocks have rather low value in estimating muscle age-
ing with respect to the physiological adaptations that typically occur due to ageing or PA. Thus, further development 
of methods is needed to gain insight into muscle tissue-specific ageing and the underlying biological pathways.
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Introduction
Human ageing is accompanied by a decline in physi-
cal activity (PA), partly resulting from a decline in 
muscle mass and function commonly referred to as 
sarcopenia [1]. These age-related changes result in 
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decreased mobility, loss of physical independence and 
increased morbidity and mortality. The precise underly-
ing molecular mechanisms behind these physiological 
changes remain poorly characterised. It is clear that indi-
vidual’s inherited genetic variants, epigenetic makeup, 
and the resultant regulation of gene expression, impacts 
of PA and PA-related phenotypes as well as the ageing 
process [2–5].
Epigenetic modifications are crucial hallmarks of age-
ing [6]. As an interface between genome and external 
factors, epigenetics forms a fundamental link between 
genotype and environment in ageing. DNA methyla-
tion is the most widely studied epigenetic mechanism. 
It may modify gene function without changing the DNA 
sequence, in part by reacting to the internal and external 
environment. Some of the alterations in DNA methyla-
tion at specific CpG (a cytosine nucleotide followed by a 
guanine nucleotide) sites correlate with chronological 
age. This finding, together with technological innovations 
in the field of microarrays, development of infrastruc-
tures for data sharing and adaptation of statistical mod-
elling methods for biological ageing studies, has offered 
promising tools for identifying epigenetic markers of 
biological age [7–10]. The novel epigenetic biomark-
ers, referred to as epigenetic clocks, are weighted sums 
of DNA methylation at specific CpG sites that can be 
used as indicators of biological age. Epigenetic clocks are 
based on penalty regression models in which chronologi-
cal age or other ageing phenotypes are predicted using 
genome-wide DNA methylation data, and optimal CpG 
sites are selected for the age predictor by the algorithm 
[7].
First-generation clocks, Horvath’s and Hannum’s, were 
developed to predict chronological age [7, 8]. The epige-
netic age estimate, DNA methylation age (DNAmAge), 
predicts differences in mortality better than chronologi-
cal age after adjusting for several known risk factors [11]. 
However, these first clocks were criticised for excluding 
CpGs whose methylation patterns may reflect deviation 
of epigenetic age from chronological age [9]. Therefore, 
the next-generation epigenetic clocks were developed to 
capture CpGs with their methylation associated with the 
functional stage and chronological age of an individual. 
PhenoAge was developed using ‘phenotypic age meas-
ure’ instead of chronological age as a reference [9], and 
GrimAge was built using a combination of DNA meth-
ylation-based surrogate biomarkers for mortality, such 
as methylation-based estimates of health-related plasma 
proteins and smoking pack-years [10]. These two novel 
epigenetic age estimates predict mortality risk better 
than Horvath’s and Hannum’s DNAmAge, while the lat-
ter ones perform better in predicting chronological age in 
large datasets [9, 10, 12].
The epigenetic clocks are developed using blood-based 
leukocyte DNA, but they seem to work in several tissues 
[7, 9]. There is some evidence suggesting that different 
tissues and organs in the same individual may vary in 
terms of their DNAmAge. The cerebellum shows slower 
ageing compared to other tissues in supercentenarians 
[13], while ageing of the liver, rather than blood, skeletal 
muscle or fat tissue, is accelerated in persons with obesity 
[14]. These observations lend support to the assumption 
that tissue-specific analyses might yield further insights 
into age-related pathologies. Muscle is the key tissue 
for physical functioning and whole-body metabolism, 
affecting age-related decline and the onset or severity 
of several age-related diseases, such as type II diabetes 
and cardiovascular diseases and even mortality [15–18]. 
Understanding of DNAmAge in muscle is sparse. How-
ever, it could be a potential biomarker of the individual 
ageing process and may offer insights into the biological 
mechanisms that regulate muscle ageing.
Potential discrepancies in DNAmAge between tissues 
could also offer explanations for the relevance of different 
environmental exposures and their influence on health 
and morbidity. PA is a modifiable behaviour that has the 
potential to slow down the rate of cellular and molecular 
damage accumulation [19] and blunt the decline in physi-
ological function with increasing age. The causal molecu-
lar and genetic links between PA and reduced age-related 
disease risk remain elusive, but it is clear that the effects 
of PA depend on its mode, intensity, duration and fre-
quency and are tissue specific [20, 21].
Very recently, the first epigenetic clock for muscle tis-
sue, ‘MEAT’ (Muscle Epigenetic Age Test), was developed 
to predict ageing in muscle [22]. It has been suggested 
that this first muscle-specific epigenetic clock can predict 
chronological age with better accuracy than, for example, 
Horvath’s DNAmAge clock, which has been previously 
shown to have reasonable accuracy in many tissues [7]. 
To the best of our knowledge, MEAT has not yet been 
investigated in relation to PA or physical function.
The aim of this study was to compare the biological 
ageing of blood and muscle tissue determined by several 
epigenetic clocks in two independent cohorts. In addi-
tion, we investigated whether ageing in these two tis-




The characteristics of the study participants, consist-
ing of groups of younger [mean age 32.9 (SD 5.3) years] 
adults (Finnish twin cohort [FTC] twins), middle-aged 
[mean 51.8 (SD 2.0) years)] adults (Estrogenic Regula-
tion of Muscle Apoptosis study [ERMA]) and older 
Page 3 of 15Sillanpää et al. Clin Epigenet          (2021) 13:110  
[mean age 63.7 (SD 4.2) years] adults (FTC twins) 
are presented in Table  1. The ERMA cohorts were all 
women, while 43% of the younger twins and 61% of the 
older twins were women. The younger and middle-aged 
adults were better educated, as 40–48% of them had 
a tertiary-level degree, while in older adults 20% had 
a tertiary-level degree. In all groups, alcohol use was 
rather low, and most were light drinkers. A quarter of 
the younger and 13% of the older twins were current 
smokers, while only 6% of the middle-aged adults were 
current smokers, which is due to the fact that smoking 
is more common among men.
All three groups were overweight on average (Table 1). 
The percentage of fat increased with age, being high-
est among the older FTC participants. The ERMA par-
ticipants had the lowest amount of lean mass, which is 
Table 1 Descriptive characteristics of the participant groups
+ missing data in education variable N = 10, ¤one drink = 12 g/100% alcohol; #Body composition is estimated by dual-energy X-ray absorptiometry; *N = 60; MVPA 
moderate to vigorous physical activity, VO2max maximal oxygen uptake
Young adults Middle-aged Older adults
FTC, N = 93 ERMA, N = 47 FTC, N = 46
Mean (SD) Mean (SD) Mean (SD)
Socio-economic and life style factors
Age, year 32.9 (5.3) 51.8 (2.0) 63.7 (4.2)
Age, range 23–42 48–55 57–69
Sex, male/female, n 62/47 –/47 18/28
Education, n (%)+
 Primary 1 (1.0) 2 (4.3) 9 (20.5)
 Secondary 52 (51.5) 26 (55.3) 26 (59.1)
 Tertiary 48 (47.5) 19 (40.4) 9 (20.5)
Smoking, n (%)
 Never 43 (46.2) 31 (66.0) 26 (56.5)
 Former 27 (29.1) 13 (27.7) 14 (30.4)
 Current 23 (24.7) 3 (6.4) 6 (13.0)
Alcohol, drinks per  week¤ 4.4 (7.4) 4.2 (4.5) 3.1 (5.5)
Body composition#
Body mass index, kg/m2 28.7 (5.8) 26.0 (3.6) 28.9 (5.7)
Fat mass, kg 30.4 (13.7) 26.0 (8.2) 30.9 (9.9)
Lean body mass, kg 51.4 (10.8) 42.6 (4.5) 46.1 (9.1)
Percentage of fat, % 34.9 (10.1) 35.8 (7.0) 38.5 (8.1)
Physical activity
Sport index 2.8 (0.99) 2.1 (1.1)
Leisure index 2.9 (0.60) 2.7 (0.80)
Work index 2.8 (0.82) 3.0 (0.51)
Self-reported physical activity, n (%)
 Low 6 (12.8)
 Medium 13 (27.7)
 High 28 (59.6)
Monitored physical activity
 MVPA, min 56.1 (32.2)
 Step counts per day 9 337 (3 378)
Physical function phenotypes
VO2max, ml/kg/min* 35.2 (8.5)
Maximal workload, W 195.8 (54.7)
Walking test, 6 min distance (m) 670 (65)
Hand grip strength (N) 331 (56)
Knee extension torque (Nm) 486 (95)
Vertical jumping height (m) 0.19 (0.043)
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logical, as this cohort included only women, who tend to 
be smaller than men.
Regarding PA, the sport and leisure indexes were 
lower and the work index was higher in older FTC par-
ticipants than in younger ones. On average, the ERMA 
participants had daily 56  min of moderate-to-vigorous 
PA (MVPA) and 9400 steps per day, indicating that they 
were quite active. Maximal oxygen uptake was 35.2  ml/
kg/min in younger FTC adults. The walking test, grip and 
knee extension strength and vertical jumping height were 
only measured in the ERMA (mean values are presented 
in Table 1).
Accuracy of different epigenetic clocks in estimating 
chronological age
In blood, all four clocks showed high correlations 
between the DNAmAge estimates and chronological age 
(r = 0.904–0.954, all p < 0.001, Fig. 1). The mean deviation 
between chronological age and predicted age was high-
est for Hannum’s DNAmAge (7.6  years) and PhenoAge 
(9.3 years). Lower deviations were observed for Horvath’s 
DNAmAge and GrimAge (5.6 and 3.6 years, respectively). 
Horvath’s clock and GrimAge tended to give lower age 
estimates to older participants than to younger ones, 
whereas the Hannum’s clock and PhenoAge DNAmAge 
estimates were consistently lower than the actual chrono-
logical age across all age groups (Fig. 1).
In muscle, DNAmAge estimated with MEAT showed 
a higher correlation with chronological age (r = 0.962) 
than DNAmAge estimated with Horvath’s pan tissue 
clock (r = 0.696, Fig. 2). However, GrimAge, although not 
developed for muscle tissue, gave age estimates that had 
an even slightly higher correlation with chronological 
age (r = 0.979). MEAT age estimates showed the highest 
accuracy (mean deviation 3.2  years). GrimAge age esti-
mates differed from chronological age by 5.0  years, and 
Horvath’s age estimates differed by 9.5 years. In younger 
individuals, all clocks tended to give higher muscle age 
estimates compared with chronological age (Fig. 2).
Clock and tissue comparison in DNAmAge and age 
acceleration
In blood, the DNAmAge correlation coefficients were sta-
tistically significant between all clocks (r = 0.862–0.943) 
(Table  2). Blood DNAmAge estimates also correlated 
with all the estimates in muscle (r = 0.624–0.939). Simi-
larly, DNAmAge estimates in muscle were significantly 
correlated between all clocks; a highest correlation was 
observed between MEAT and GrimAge (r = 0.940), while 
the correlations between Horvath’s clock and GrimAge 
and MEAT were lower (r = 0.651 and 0.714, respectively).
All DNAmAge acceleration estimates were also corre-
lated in blood, but the associations were weak to mod-
est (r = 0.244–0.566, Table  3). In muscle, the strongest 
correlation was found between Horvath’s and MEAT 
DNAmAge acceleration estimates (r = 0.365). Unlike the 
DNAmAge results, the blood DNAmAge acceleration 
values were at most very weakly (all r < 0.15) correlated 
with muscle age acceleration estimates.
Within-pair analysis of age acceleration for monozygotic 
(MZ) pairs
In blood, pairwise correlations were highest in Horvath’s 
(r = 0.807) and Hannum’s age acceleration (r = 0.824, 
Additional file  1, Fig.  1). Slightly lower within-pair cor-
relations were observed with PhenoAge and GrimAge 
acceleration (r = 0.774 and r = 0.617, respectively). In 
muscle tissue, within-pair analysis showed similar mod-
erate correlations for all three clocks (r = 0.523–0.585, 
Additional file 1, Fig. 2).
Associations between epigenetic clocks and physical 
activity
Associations between DNAmAge acceleration estimates 
and PA were analysed using both self-reported (FTC and 
ERMA) and accelerometer-measured activity (ERMA).
In blood, DNAmAge acceleration estimates had minor 
or non-existent associations with PA (Additional file  2, 
Table  1). In FTC, a weak association of borderline sig-
nificance was observed between slower age acceleration 
GrimAge and a higher leisure index. In ERMA, slower 
age acceleration estimates in GrimAge were evident in 
the medium-activity group compared to the low-activity 
participants, and this association attenuated slightly after 
further adjustments for sex and smoking.
In muscle tissue, the muscle-specific MEAT clock was 
not associated with PA. Higher DNAmAge accelera-
tion estimated by GrimAge was associated with a higher 
amount of MVPA and daily steps (Table  4), with con-
sistent point estimates (although with larger confidence 
intervals from the two other clocks).
In addition to a separate analysis of the two cohorts, 
we conducted an analysis using both cohorts in the same 
model, aiming to study associations between DNAmAge 
estimates and moderate to high-intensity PA. The ERMA 
and FTC participants were classified into low-, medium- 
and high-activity groups based on tertials in the variables 
MVPA (min) and sport index, respectively. This analysis 
revealed accelerated ageing among high-activity partici-
pants compared to low-activity participants in muscle 
tissue with Horvath’s clock after adjusting for sex and 
smoking (Table 4).
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Associations between epigenetic clocks and body 
composition
In the next chapters, for consistency, we only report 
results with regard to the adjusted models. Associations 
between blood and muscle DNAm age acceleration esti-
mates and BMI and body composition (fat mass, lean 
mass and percentage of fat estimated with DXA) were 
investigated by combining the FTC and ERMA cohorts 
into the same models.
In blood, age accelerations (Horvath, Hannum and 
GrimAge) were not associated with body composition 
after adjustments (Additional file 1, Table 2).
Associations between muscle DNAmAge accelera-
tion estimates and BMI were not seen. Further, a higher 
Fig. 1 Scatter plots, regression lines (dotted lines), reference lines (solid lines) and Pearson’s correlation coefficients for each of the four predicted 
DNA methylation ages (DNAmAge) and chronological age in blood. Each dot represents one participant. Black dots denote participants from the 
FTC cohort and blue dots participants from the ERMA cohort
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Horvath’s and GrimAge acceleration in muscle was asso-
ciated in the same direction with lower fat mass and 
fat percent, even after covariate adjustments (Table  5). 
Higher Horvaths’ age acceleration and MEAT age accel-
eration were not associated with body composition in 
adjusted models.
Associations between epigenetic clocks and physical 
functioning
Associations between blood and muscle DNAmAge 
acceleration estimates and maximal oxygen uptake were 
analysed using the younger FTC cohort. No associations 
were seen in blood or muscle after adjusting for sex and 
smoking (Table 4).
Fig. 2 Scatter plots, regression lines (dotted lines), reference lines (solid lines) and Pearson’s correlation coefficients for each of the three predicted 
DNA methylation ages (DNAmAge) and chronological age in muscle. Each dot represents one participant. Black dots denote participants from the 
FTC cohort and blue dots participants from the ERMA cohort
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Other analyses of physical function (walking distance, 
muscle strength and power) were conducted in the 
ERMA cohort. Age acceleration estimates in blood and 
in muscle tissue were not associated with physical func-
tion phenotypes (Additional file 1, Table 2).
Sensitivity analyses
Because our study sample included 50 MZ and 4 DZ twin 
pairs with discordant BMI, it was important to deter-
mine whether the discordance would have affected the 
observed results. Therefore, we conducted several sensi-
tivity analyses, excluding either the leaner or heavier twin 
in a pair from the analysis (Additional file 3). In general, 
the associations were not dependent on whether the anal-
ysis was conducted without the heavier or leaner twin in 
a pair. However, it must be noted that, after excluding 
the heavier twins, higher MEAT age acceleration was 
associated with lower maximal oxygen consumption 
(r = -0.366, p = 0.018) compared to a weaker association 
(r = -0.288) when excluding the leaner twin. In further 
linear regression analyses with both twins in the model, 
the association remained significant after adjusting for 
twin dependency, gender and smoking (β = -0.102, SE 
0.046, p = 0.034).
Discussion
Muscle tissue is important with respect to human health, 
well-being and quality of life. Its proper function is essen-
tial for locomotion and other important tasks related to 
energy metabolism, temperature regulation and recov-
ery from adverse health events. Ageing challenges the 
optimal functioning of muscle tissue. Typical age-related 
changes include accelerated decline in muscle function 
and quantity, which results in problems in functional 
capacity and health [23]. A method for estimating and 
predicting muscle ageing would be helpful in identify-
ing persons who are at risk for age-related decline in 
Table 2 Correlation coefficients between chronological age and different DNAmAge estimates in total body (blood) and muscle 
tissue
Horvath Hannum PhenoAge GrimAge Horvath GrimAge MEAT
Blood Horvath 1 Correlation p-value
DNAmAge Hannum 0.928 1 1
PhenoAge 0.922 0.943 1 >0.8 <0.001
GrimAge 0.862 0.931 0.897 1 >0.6 <0.001
Muscle Horvath 0.732 0.703 0.624 0.632 1
DNAmAge GrimAge 0.86 0.937 0.878 0.939 0.651 1
MEAT 0.876 0.927 0.874 0.913 0.714 0.940 1
Blood DNAmAge Muscle DNAmAge
DNAmAge DNA methylation age in years, MEAT muscle epigenetic age test
Table 3 Correlation coefficients between different DNAmAge acceleration estimates in blood and muscle tissue
Horvath Hannum PhenoAge GrimAge Horvath GrimAge MEAT
Blood DNAmAge Horvath 1 Correlation p-value
Acceleration Hannum 0.522 1 1
PhenoAge 0.476 0.566 1 >0.4 <0.001
GrimAge 0.244 0.361 0.364 1 >0.2 <0.01
<0.2 n.s.
Muscle DNAmAge Horvath 0.044 0.146 -0.082 0.042 1
Acceleration GrimAge -0.057 0.041 -0.054 0.044 0.141 1
MEAT 0.117 0.107 0.001 0.033 0.365 -0.093 1
Blood DNAmAge acceleration Muscle DNAmAge acceleration
DNAmAge DNA methylation age, MEAT muscle epigenetic age test
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functional capacity or morbidities, and it could also fur-
nish mechanisms that are potential targets for treatments 
and interventions to improve muscle functioning among 
ageing populations. We investigated novel genome-wide 
epigenetic scores, developed to predict age, age span and 
healthy ageing, in blood and muscle tissue [7–10, 22]. 
Our results showed that these clocks are mainly suitable 
for predicting chronological age from both tissues, but 
variation in age estimates was not systematically associ-
ated with the variation in physical functional phenotypes, 
which suggests that the clocks lack value for research and 
health promotion purposes.
Tissue specificity
We found a strong linear relationship between chrono-
logical age and DNA methylation age estimates (i.e. Han-
num’s clock, Horvath’s clock, GrimAge, PhenoAge and 
MEAT) in both blood and skeletal muscle tissues. This 
was expected, as most of these clocks have been devel-
oped to predict chronological age, and age is one com-
ponent of the GrimAge algorithm. We also replicated 
the finding regarding the poorer calibration of Horvath’s 
clock in age estimation in muscle [7, 22]. The good overall 
performance of these clocks in predicting chronological 
age has been demonstrated repeatedly in previous stud-
ies [4, 10, 22, 24]. However, the age acceleration of blood 
was not associated with the age acceleration in muscle 
by any of the clocks, suggesting different ticking rates in 
blood and muscle. We also found age acceleration esti-
mates of blood to be more similar within twin pairs than 
age acceleration estimates of muscle, suggesting either a 
larger familial component in blood-based age accelera-
tion estimates or larger heterogeneity in muscle tissue 
composition. Because we only analysed MZ pairs, we 
Table 4 Associations between DNAmAge age acceleration estimates and physical activity in muscle
Model 1. Linear regression analysis with one predictor. Model 2. As Model one, but adjusted for family relatedness, sex and smoking. Model 3. As model one, but 
adjusted for smoking. Step counts per day calculated per 100 counts. MEAT, muscle epigenetic age test. FTC, Finnish twin cohort; ERMA, Estrogenic Regulation of 
Muscle Apoptosis study. In first analysis, we formed tertiles based on the amount of moderate to vigorous physical activity (MVPA, ERMA cohort) and sport indexes 
(FTC cohort) and pooled the data from these two cohorts
Muscle DNAmAge acceleration
Horvath GrimAge MEAT
β (SE) p-value R2 β (SE) p-value R2 β (SE) p-value R2
FTC& ERMA (N = 183)
MVPA
Low (ref ) Model 1 0.045 0.022 0.002
Medium 0.456 (0.661) 0.492 0.152 (0.273) 0.578 0.120 (0.631) 0.849
High 1.842 (0.660) 0.006 0.531 (0.272) 0.053 0.338 (0.630) 0.592
Low (ref ) Model 2 0.111 0.038 0.005
Medium − 0.040 (0.667) 0.951 0.059 (0.299) 0.843 0.156 (0.683) 0.820
High 1.573 (0.786) 0.048 0.493 (0.268) 0.068 0.336 (0.682) 0.637
FTC (N = 136)
Leisure index Model 1 0.584 (0.516) 0.259 0.010 0.008 (0.189) 0.967 0.000 − 0.763 (0.472) 0.109 0.018
Model 2 0.483 (0.538) 0.372 0.109 − 0.019 (0.190) 0.922 0.025 − 0.740 (0.523) 0.161 0.020
Sport index Model 1 0.899 (0.338) 0.009 0.050 0.068 (0.123) 0.592 0.002 − 0.221 (0.319) 0.491 0.004
Model 2 0.756 (0.440) 0.091 0.136 0.042 (0.127) 0.740 0.026 − 0.216 (0.377) 0.569 0.006
ERMA (N = 47)
Monitored PA
MVPA, min Model 1 0.030 (0.017) 0.079 0.067 0.021 (0.008) 0.013 0.129 0.023 (0.016) 0.163 0.043
Model 3 0.032 (0.018) 0.075 0.080 0.022 (0.009) 0.014 0.161 0.021 (0.017) 0.226 0.049
Step counts per day Model 1 0.003 (0.002) 0.114 0.055 0.002 (0.001) 0.007 0.153 0.001 (0.002) 0.548 0.008
Model 3 0.003 (0.002) 0.105 0.068 0.002 (0.001) 0.006 0.189 0.001 (0.002) 0.758 0.028
Self-reported PA
Low (ref ) Model 1 0.075 0.002 0.056
Medium 3.22 (1.82) 0.084 0.296 (0.965) 0.761 2.82 (1.79) 0.122
High 2.92 (1.66) 0.085 0.200 (0.880) 0.821 1.58 (1.63) 0.338
Low (ref ) Model 2 0.082 0.035 0.079
Medium 3.21 (1.87) 0.093 0.209 (0.978) 0.832 2.70 (1.82) 0.144
High 2.96 (1.72) 0.094 0.101 (0.903) 0.912 1.34 (1.68) 0.428
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cannot distinguish genetics from environmental effects 
(e.g. similar occupation or PA) that the twins share in the 
familial component estimate.
Regarding our hypothesis that PA will slow down age 
acceleration in muscle, we found that the age acceleration 
estimates from Horvath’s clock and GrimAge showed 
a minor but statistically significant positive association 
with PA measures. These results suggest that higher PA 
would be linked to accelerated biological ageing in mus-
cle. As PA and ageing typically result in opposite struc-
tural and functional changes in muscle, it seems unlikely 
that PA would accelerate ageing processes in the mus-
cle. Instead, we believe that the findings reflect the low 
capacity of the epigenetic clock algorithms to measure 
functional muscle ageing. Possible explanations for this 
include cell heterogeneity and differences in methyla-
tion profiles and structure between white blood cells and 
muscle tissue. Blood cells represent a constantly dividing 
cell population, while adult muscle tissue is more hetero-
geneous. It mainly includes multinucleated post-mitotic 
myofibers that do not divide, but also a smaller popula-
tion of quiescent muscle stem cells, called satellite cells, 
which can re-enter the cell cycle to initiate proliferation 
and donate nuclei to muscle fibres. Furthermore, a small 
contribution to the muscle tissue DNA pool is provided 
by a network of capillaries formed by endothelial and 
epithelial cell layers as well as a variable, small amount 
of infiltrated leucocytes and fat and connective tissue 
cells. PA stimulates the formation of satellite cells, which 
are essential for muscle regeneration and are responsible 
for muscle growth [25]. Skeletal muscle cells and satel-
lite cells are differentially methylated, and PA may pre-
dispose them to different epigenetic changes depending 
on age [26]. Satellite cells are important in the regenera-
tion of muscle after cumulative injuries in exercisers, but 
their functionality declines with increasing age [27]. In 
addition, ageing and PA typically lead to different struc-
tural changes in muscle. In particular, strength training 
increases the size of muscle cells, while ageing is associ-
ated with smaller and weaker muscle cells and changes 
in the cell-type composition of tissue. However, some 
structural changes caused by ageing and PA are shared, 
both resulting in increasing infiltration of fat inside the 
muscles [28]. However, in the case of PA, infiltrated fat 
is mainly lipid droplets that do not contain DNA. Muscle 
tissue samples, although carefully collected and with all 
Table 5 Associations between DNAmAge age acceleration estimates, body composition and physical function in muscle
Model 1. Linear regression analysis with one predictor. Model 2. As Model one, but adjusted for family relatedness, sex and smoking. Model 3 as model one, but 
adjusted for smoking. MEAT, muscle epigenetic age test. FTC, Finnish twin cohort; ERMA, Estrogenic Regulation of Muscle Apoptosis study
Muscle DNAmAge Acceleration
Horvath GrimAge MEAT
β (SE) p-value R2 β (SE) p-value R2 β (SE) p-value R2
FTC& ERMA (N = 186)
Body mass index, Model 1 − 0.049 (0.050) 0.323 0.005 − 0.037 (0.020) 0.072 0.018 − 0.014 (0.047) 0.759 0.001
kg/m2 Model 2 − 0.047 (0.048) 0.334 0.014 − 0.036 (0.020) 0.070 0.034 − 0.011 (0.060) 0.848 0.002
Fat mass, kg Model 1 − 0.058 (0.023) 0.012 0.029 − 0.020 (0.009) 0.036 0.024 − 0.006 (0.022) 0.780 0.000
Model 2 − 0.050 (0.025) 0.048 0.009 − 0.018 (0.008) 0.029 0.038 − 0.007 (0.025) 0.788 0.003
Lean body mass, kg Model 1 0.084 (0.027) 0.002 0.045 0.012 (0.011) 0.290 0.006 − 0.004 (0.026) 0.875 0.000
Model 2 0.040 (0.052) 0.437 0.073 0.002 (0.019) 0.909 0.018 − 0.018 (0.048) 0.710 0.004
Fat percent, % Model 1 − 0.107 (0.029)  < 0.001 0.064 − 0.030 (0.012) 0.014 0.032 0.008 (0.029) 0.771 0.001
Model 2 − 0.078 (0.038) 0.042 0.098 − 0.028 (0.013) 0.041 0.039 0.011 (0.038) 0.771 0.003
FTC (N = 60)
Maximal oxygen Model 1 0.117 (0.058) 0.048 0.066 0.037 (0.020) 0.074 0.054 − 0.077 (0.044) 0.082 0.051
uptake, ml/kg/min Model 2 0.034 (0.069) 0.626 0.195 0.028 (0.032) 0.393 0.075 − 0.079 (0.042) 0.067 0.071
ERMA (N = 47)
Walking test 6 min Model 1 0.002 (0.009) 0.811 0.001 0.007 (0.004) 0.138 0.050 − 0.005 (0.008) 0.506 0.009
M Model 3 0.000 (0.009) 0.959 0.010 0.006 (0.005) 0.187 0.070 − 0.004 (0.008) 0.632 0.014
Hand grip strength Model 1 0.001 (0.100) 0.904 0.000 0.000 (0.005) 0.959 0.000 − 0.012 (0.009) 0.203 0.036
N Model 3 0.001 (0.010) 0.913 0.009 0.000 (0.005) 0.973 0.034 − 0.012 (0.009) 0.213 0.051
Knee extension Model 1 0.010 (0.006) 0.098 0.066 0.004 (0.003) 0.170 0.044 − 0.003 (0.005) 0.508 0.007
torque, Nm Model 3 0.010 (0.006) 0.115 0.074 0.004 (0.003) 0.285 0.066 − 0.004 (0.005) 0.486 0.056
Vertical jumping Model 1 1.43 (12.95) 0.915 0.000 6.246 (6.545) 0.345 0.020 − 11.9 (12.0) 0.326 0.021
height, cm Model 3 0.679 (13.3) 0.960 0.009 5.431 (6.664) 0.420 0.048 − 12.8 (12.3) 0.302 0.040
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visible fat and connective tissue removed, may still con-
tain traces of these other tissues. Whether this explains 
our finding that both the Horvath’s and GrimAge clock 
estimates were significantly associated with the amount 
of body fat in muscle tissue remains unanswered.
Physical activity
In our study, slower epigenetic age acceleration in blood 
was weakly or non-significantly associated with higher 
PA, depending on the epigenetic age estimate and PA 
measurement method. Substantial associations were 
observed only with the GrimAge epigenetic clock and 
with self-reported PA data. The results are in line with 
those of previous studies, which have reported null find-
ings [4, 29] using Horvath’s clock and weak associations 
using GrimAge [30–32]. The lack of consistent findings 
regarding the association between epigenetic ageing 
and PA in our study is likely explained by different fea-
tures of epigenetic age algorithms and PA data collec-
tion methods. We have previously shown that LTPA is 
associated with slower ageing, while occupational PA is 
associated with accelerated ageing [30]. This may explain 
why device-based measures of PA representing whole 
day PA did not show associations with epigenetic ageing, 
although they are typically considered more reliable than 
self-reports in estimating PA.
Physical functioning
In line with previous studies [33, 34], associations 
between DNAmAge estimates and different physi-
cal function phenotypes were non-existent or minor in 
blood. Within the same individual, different tissues may 
yield different age estimates [13, 14, 35]. Some previous 
studies have suggested that tissue and cell type-specific 
analyses might be able to track age-related pathologies 
in target tissues. Muscle is the key tissue affecting age-
related decline in physical functioning and PA, and thus 
we hypothesised that muscle tissue might better reflect 
biological ageing relevant to functional capacity. We 
found that the muscle-specific epigenetic clock MEAT 
is not associated with physical functioning, PA or body 
composition. MEAT was constructed only to predict 
chronological age without using any other biological 
phenotype data and may therefore be independent from 
molecular alterations caused by changes in the modifi-
able behavioural phenotypes, such as PA. Muscle-specific 
clocks need to be further developed taking into account 
biological and functional parameters, as has been done 
with respect to the other epigenetic clocks GrimAge and 
PhenoAge [9, 10], which, however, were built for blood 
tissue only. We also tested the two multi-tissue epige-
netic clocks, Horvath’s and GrimAge with muscle tissue. 
In addition to the previously mentioned association with 
body fat, the only significant association was between 
Horvath’s age acceleration and cardiorespiratory fitness. 
However, this weak association attenuated after adjusting 
for sex and smoking, suggesting that it originates mostly 
from biological sex differences and the smoking habits of 
the participants.
Strengths and limitations
To the best of our knowledge, this study is the first to 
examine the associations between epigenetic clocks and 
PA and physical functioning in muscle tissue, utilising the 
novel muscle clock MEAT developed by Voisin et al. [22]. 
Our methods for estimating PA and function covered a 
wide variety of phenotypes measured in a research labo-
ratory by trained professionals as well as measurement of 
PA with reliable device-based methods under free-living 
conditions. By using two independent datasets, we were 
able to cover a large age span of individuals representing 
the same genetic ancestry. Since we only included indi-
viduals with both blood and muscle data available, we 
acknowledge that our sample size (in total N = 186) might 
not be sufficient to capture the small effect sizes that 
some phenotypes may have with respect to accelerated 
ageing. However, the observed trends in the associations 
between blood GrimAge age acceleration and self-
reported PA corresponds to previously reported results 
in a larger sample [30]. Our sample also included twins 
with discordant BMI, which may result in larger within-
pair differences in methylation profiles. However, we 
conducted comprehensive sensitivity analyses, excluding 
either heavier or leaner twins from pairs discordant for 
BMI from the analysis, and the results were very similar 
(Additional file 3). Our results should be considered pre-
liminary findings that need to be replicated with other, 
larger cohorts.
Conclusions
Both multi-tissue and muscle-specific novel epigenetic 
clocks seem to perform well in estimating chronological 
age in muscle tissue. Based on current knowledge and our 
results, however, these epigenetic clocks have rather low 
value in estimating muscle ageing with respect to physi-
ological adaptations that typically occur due to ageing or 
PA. Practical issues related to the sampling of muscle tis-
sue have limited the development of epigenetic research 
and scoring methods in this area. As age-related func-
tional limitations are expanding rapidly due to increasing 
life expectancy throughout the world, there is an urgent 
need to gain more insight into muscle tissue-specific age-
ing and the underlying biological pathways. This type of 
knowledge could help the development of medical and 
lifestyle treatments for age-related functional limitations 
and muscle pathologies.
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Methods
Study populations
The data used in the current analysis originate from two 
Finnish population-based cohort studies: the FTC and 
the ERMA study.
In brief, FTC includes three large cohort studies: (1) 
study of twins born before 1958, an older twin cohort; (2) 
in 1975–1979, Finntwin16 (FT16); and (3) in 1983–1987, 
Finntwin12 (FT12) [36–38]. All three twin cohorts have 
been studied in an intensive longitudinal manner, and 
several subprojects have been conducted in laboratory 
conditions. All twins who had taken part in clinical in-
person sub-studies with sampling for both whole blood 
and muscle tissue, subsequent DNA methylation analyses 
and phenotype collection were included (N = 139) [39, 
40]. The dataset comprises two age groups: young adults 
from 23 to 44 years of age (N = 93) and older adults from 
57 to 69  years of age (N = 46). The dataset includes 54 
twin pairs, who were discordance for body mass index 
(BMI; difference more than 3  kg/m2) and have partici-
pated in the sub-study including laboratory measure-
ments for body composition and physical performance 
[40]. Zygosity of the twins was confirmed by genetic anal-
ysis of multiple polymorphic markers. The majority (45 
pairs) were MZ, and only four same sex dizygotic twin 
pairs were present.
The recruitment process, study design and methodol-
ogy of the ERMA study has been described in detail else-
where [41]. In brief, the original ERMA cohort includes 
47- to 55-year-old women living in the city of Jyväskylä 
or neighbouring municipalities. The study participants 
were randomly selected from the national registers of 
the Digital and Population Data Services Agency, Hel-
sinki (dvv.fi). The ERMA study was designed to reveal 
how hormonal differences during the menopausal stages 
affect the physiological and psychological functioning of 
middle-aged women. The participants for DNA extrac-
tion and subsequent methylation analysis (N = 47) were 
randomly selected amongst ERMA participants who had 
both whole blood and muscle tissue samples available 
and who did not have missing or low-quality accelerom-
eter data in PA measures.
Ethics
The FTC data collection and analysis were approved by 
the ethics committee of the Helsinki University Cen-
tral Hospital (Dnro 249/E5/01, 270/13/03/01/2008, 
154/13/03/00/2011), and the ERMA study was approved 
by the ethics committee of the Central Finland health 
care district in 2014 (K-SSHP Dnro 8U/2014). Writ-
ten informed consent was provided by the participants 
before the sample collection and PA and functioning 
measurements.
Outcome measures
Tissue sampling and DNA extraction
Whole blood samples were collected in fasting conditions 
from the antecubital vein. Muscle biopsy samples were 
obtained from the mid-part of the m. vastus lateralis, 
defined as the midpoint between the greater trochanter 
and the lateral joint line of the knee, by percutaneous 
needle biopsy under local anaesthesia. Following the 
removal of all visible fat residues, connective tissue and 
blood, the biopsy samples were frozen in liquid nitrogen 
and stored at -150 °C until use. Blood white cell and mus-
cle tissue DNA were extracted using a DNeasy Blood & 
Tissue Kit (Qiagen, Cat No./ID: 69,504).
Genome‑wide methylation analysis
High molecular weight DNA was bisulfite-converted 
using an EZ-96 DNA Methylation-Gold Kit (Zymo 
Research, Irvine, CA, USA). Genome-wide DNA meth-
ylation was measured using Illumina’s Infinium Meth-
ylationEPIC BeadChip (Illumina, San Diego, CA, USA) 
according to the manufacturer’s instructions. The Illu-
mina BeadChip measures single-CpG resolution DNA 
methylation levels across the human genome.
Data preprocessing
Data were preprocessed using the R package minfi. 
Detection p-values comparing the total signal for each 
probe to the background signal level were calculated to 
evaluate the quality of the samples [42]. Poor-quality 
samples (mean detection p > 0.01) were excluded from 
further analysis. Beta values representing CpG meth-
ylation levels were calculated as the ratio of methylated 
intensities (M) to the overall intensities (Beta value = M/
(M + U + 100), where U is unmethylated probe inten-
sity. Data were normalised using the single-sample Noob 
normalisation and Beta Mixture Quantile normalisation 
methods [43, 44].
Epigenetic clocks
The resulting methylation data were uploaded to an 
online epigenetic age calculator (https:// dnama ge. genet 
ics. ucla. edu/ new), selecting the options ‘Normalise data’ 
and ‘Advanced analysis’ to generate the various clock 
estimates [7]. For blood, the four most commonly used 
epigenetic age estimates, Horvath’s and Hannum’s DNA 
methylation age (DNAmAge), PhenoAge and Grim-
Age, were computed. For muscle tissue, only Horvath’s 
DNAmAge and GrimAge were used, as Hannum’s clock 
and PhenoAge were clearly not suitable for muscle tis-
sue according to current knowledge and our preliminary 
analyses, which showed very low DNAmAge estimates 
for muscle tissue samples (data not shown). In addi-
tion to these two epigenetic clocks, the novel MEAT 
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was computed using the open access R-package MEAT 
available on Bioconductor [22]. The data were screened 
for potential outliers e.g. due to methodological bias, or 
mistakes in sampling or data processing steps by compar-
ing epigenetic age estimate of each sample to the mean 
epigenetic age of the study population. No outliers were 
detected in ERMA or FTC data. DNAmAge age accel-
eration, which describes the rate of individual ageing 
and is unrelated to chronological age, was calculated 
separately for FTC and ERMA participants [Age accel-
eration = residual (linear model (predicted age ~ chrono-
logical age)].
Physical activity
The Baecke questionnaire was used to assess PA in FTC 
[45]. The questionnaire consists of 16 items, from which 
three indexes were calculated: the work index refers 
to PA at work, the sport index refers to sports partici-
pation during leisure time and the leisure-time index 
refers to PA during leisure time excluding sport activi-
ties. All responses were given on a five-point scale, with 
the exception of questions on main occupation and the 
types of two main sports. In the original publication, the 
test–retest reliability of the work index, sport index and 
leisure-time indices were 0.88, 0.81 and 0.74, respectively 
[45]. The Baecke questionnaire has been validated for 
cardiorespiratory fitness among Finnish twins [46].
In the ERMA study, PA was monitored using hip-
worn GT3X + or wGT3X + ActiGraph accelerometers 
at 60 Hz (Pensacola, FL) for seven consecutive days [47, 
48]. The raw acceleration data were converted into 60-s 
epoch counts and divided into the mean daily duration 
spent at different PA intensities using tri-axial vector 
magnitude cut-points of 450 counts per minute (cpm), 
2690 cpm and 6166 cpm to separate sedentary from light 
PA, light from moderate PA and moderate from vigorous 
PA, respectively; 25,000 cpm was used as an upper limit. 
Mean time spent at MVPA intensity level and daily steps 
during waking hours were calculated for each partici-
pant. Self-reported PA was assessed with a seven-scale 
questionnaire [49, 50]. Due to the low number of partici-
pants in some categories, answers were re-categorised as 
low, medium and high activity.
Body composition
Anthropometrics and body composition were measured 
after overnight fasting. Body mass index was calculated 
as a function of measured body weight and height (kg/
m2). Percentage body fat, total body fat mass and lean 
body mass were measured through dual-energy X-ray 
absorptiometry (DXA, Lunar Prodigy).
Physical functioning
Physical function phenotypes included measures for both 
cardiorespiratory fitness and upper and lower extremity 
muscle strength and muscle power. Maximal oxygen con-
sumption was measured only in FTC and other pheno-
types and only in the ERMA cohort.
Maximal oxygen consumption, which describes the 
level of cardiorespiratory fitness, was measured with a 
graded maximal exercise test using an electrically braked 
bicycle ergometer, as described earlier [51]. The ini-
tial workload (40 W for women and 50 W for men) was 
increased by 40 W (women) or 50 W (men) every 3 min 
until the maximal exercise capacity was reached (i.e. until 
volitional exhaustion following generally approved lim-
its) [46]. Oxygen uptake (V̇O2), carbon dioxide produc-
tion (VCO2), ventilation, breathing frequency and other 
standardised respiratory parameters were measured con-
tinuously breath by breath with a Vmax spiroergometer 
(Sensormedics, Yorba Linda, CA). A strict calibration 
protocol was followed to ensure data quality [46].
The 6-min walking test, in which the participants 
attempted to walk the longest possible distance in the 
allotted time, was performed on a 20-m indoor track. 
Participants were instructed to complete as many laps as 
possible within 6 min, and the distance they walked was 
recorded [52]. The 6-min walking test is a performance-
based measure of functional exercise capacity, and it can 
be used as an indicator of exercise tolerance or cardi-
orespiratory fitness. A standardised protocol and safety 
guidelines issued by the American Thoracic Society (ATS 
Committee on Proficiency Standards for Clinical Pulmo-
nary Function Laboratories 2002) were followed.
Hand grip strength (N) and knee extension torque (Nm) 
were measured using an isometric dynamometer (Good 
Strength, Metitur Oy, Jyväskylä, Finland) [53]. To test 
hand grip strength, the participant’s dominant arm was 
fixed to the armrest of the dynamometer chair with the 
elbow flexed at a 90° angle, while knee extension strength 
was measured at a knee angle of 60° from full extension. 
During the measurements, participants were encour-
aged verbally to squeeze the handle or extend their 
knee to produce maximal contraction. Each participant 
was allowed to have three to five trials with 1  min rest 
between trials. The best attempt with the highest 2–3  s 
lasting peak force value was used in the analysis. Hand-
grip strength measurement can be used as an indicator of 
general muscle strength among older people [54]. Maxi-
mal Nm was calculated from the best attempt measured 
in Newtons (N) multiplied by lower leg length (the dis-
tance between the lateral joint line of the knee and the 
midline of a cuff around the ankle) [55].
Vertical jumping height (cm) was calculated from flight 
time during a maximal effort countermovement jump 
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and measured on a contact mat [56]. Three maximal 
efforts were conducted, and the best result was used in 
the analysis. Vertical jumping height can be used as an 
estimate of lower body muscle power (i.e. the ability of 
the neuromuscular system to produce the greatest possi-
ble force as rapidly as possible). Lower extremity muscle 
power declines earlier and to a greater extent than mus-
cle strength during ageing [57]. It also correlates strongly 
with mobility among older people [58].
Other variables
Sociodemographic variables and life habits were collected 
with validated questionnaires. These questionnaires have 
been published previously on the FTC webpage (https:// 
wiki. helsi nki. fi/ displ ay/ twins tudy) and regarding the 
ERMA study as supplementary digital contents [41]. 
Level of education was classified into primary, second-
ary and tertiary education groups following the levels of 
the Finnish education system. Use of alcohol was calcu-
lated as the number of alcoholic drinks (1 drink is 12 g 
ethanol) consumed per week, with alcohol consumption 
computed based on quantity and frequency measures of 
alcohol beverage use [59, 60]. Smoking was classified as 
never, former (abstinence for at least 6 months) and cur-
rent (daily or occasional) smoker.
Statistical analysis
Statistical analyses were carried out with Stata 16 soft-
ware (StataCorp, Inc. College Station, TX, USA) and 
R studio (3.6.0). Data are shown as means and stand-
ard deviations unless otherwise stated. The mean 
absolute difference between the predicted DNAmAge 
and chronological age was calculated to see whether 
the estimated DNAmAge was younger or older com-
pared to the chronological age. Correlation coefficients 
were computed to estimate the level of similarity in 
DNAmAge estimates in different tissues. DNAmAge 
age acceleration was calculated for all participants 
as the residuals from a linear regression model of the 
DNAmAge estimate on chronological age. Intraclass 
correlation coefficients (ICC) were computed for the 
MZ twin pairs to estimate the level of within-pair 
similarity. Associations between different DNAmAge 
acceleration estimates, PA, body composition and PA-
related phenotypes were analysed using linear regres-
sion analysis, which were further adjusted for sex and 
smoking. In the models, the within-pair dependency of 
twin individuals was taken into account using the clus-
ter option in the analysis. The level of significance was 
set at p ≤ 0.05.
Abbreviations
BMI: Body mass index, kg/m2; CpG: A cytosine nucleotide followed by a 
guanine nucleotide; DNAmAge: DNA methylation age; ERMA: Estrogenic 
Regulation of Muscle Apoptosis study; FTC: Finnish twin cohort; ICC: Intraclass 
correlation coefficients; LTPA: Leisure time physical activity; MEAT: Muscle 
epigenetic age test; MVPA: A moderate-to-vigorous physical activity; MZ: 
Monozygotic; PA: Physical activity.
Supplementary Information
The online version contains supplementary material available at https:// doi. 
org/ 10. 1186/ s13148- 021- 01094-6.
Additional file 1: Within-pair correlations in age acceleration in blood and 
in muscle. Additional file 2: Associations between DNAmAge age accel-
eration estimates and body composition and physical activity in blood. 
Additional file 3: Sensitivity analyses related to twin pair discordance in 
body mass index.
Acknowledgements
ES was supported by the Academy of Finland (Grant No. 260001), the Juho 
Vainio foundation and the Yrjö Jahnsson foundation. VK was supported 
by the Academy of Finland (275323). KHP was funded by the Academy of 
Finland (Grant Nos. 314383 and 266286), the Academy of Finland Center of 
Excellence in Research on Mitochondria, Metabolism and Disease (FinMIT; 
Grant No. 272376), the Finnish Medical Foundation, the Gyllenberg Founda-
tion, the Novo Nordisk Foundation (Grant Nos. NNF17OC0027232 and 
NNF10OC1013354), the Finnish Diabetes Research Foundation, the Finnish 
Foundation for Cardiovascular Research, Government Research Funds, the 
University of Helsinki and Helsinki University Hospital. JK was supported by the 
Academy of Finland (213506, 308248, 312073, 336823), EC FP5 GenomEUtwin, 
NIH NIH/NHLBI (grant HL104125), EC MC ITN Project EPITRAIN and Sigrid 
Juselius Foundation. MO was supported by the Academy of Finland (297908 
and 251316), EC MC ITN Project EPITRAIN, University of Helsinki Research 
Funds and Sigrid Juselius Foundation. EKL was supported by the Academy of 
Finland (309504 and 314181) and the Juho Vainio Foundation. The Gerontol-
ogy Research Center is a joint effort between the University of Jyväskylä and 
the University of Tampere.
Authors’ contributions
ES, EKL and MO designed the study, AH and AK prepossessed methylation 
data and formed epigenetic age estimates. ES and AH performed the analysis 
and interpretation of the data and drafted the first version of the manuscript. 
EKL, JK, UMK, MO, AP and KHP participated in the data interpretation and plan-
ning the statistical analyses. VK, ELK, SS, UMK and THT designed and collected 
the ERMA phenotype dataset. JK, KHP and MO designed and collected the FTC 
dataset. All authors read and approved the final manuscript.
Availability of data and materials
All twin data used in the current study are located within the Biobank of the 
National Institute for Health and Welfare, Finland. All the biobanked data are 






The authors declare that they have no competing interests.
Author details
1 Gerontology Research Center, Faculty of Sport and Health Sciences, 
University of Jyväskylä, P.O. Box 35 (VIV), 40014 Jyväskylä, Finland. 2 Institute 
for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. 
3 Department of Public Health, University of Helsinki, Helsinki, Finland. 4 Faculty 
of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland. 5 LIKES 
Page 14 of 15Sillanpää et al. Clin Epigenet          (2021) 13:110 
Research Centre for Physical Activity and Health, Jyväskylä, Finland. 6 Obesity 
Research Unit, Research Program for Clinical and Molecular Metabolism, 
Faculty of Medicine, University of Helsinki, Helsinki, Finland. 7 Obesity Center, 
Endocrinology, Abdominal Center, Helsinki University Hospital and University 
of Helsinki, Helsinki, Finland. 
Received: 12 February 2021   Accepted: 26 April 2021
References
 1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 
1997;127(5 Suppl):990S–991S.
 2. Aasdahl L, Nilsen TIL, Meisingset I, Nordstoga AL, Evensen KAI, Paulsen J, 
et al. Genetic variants related to physical activity or sedentary behaviour: 
a systematic review. Int J Behav Nutr Phys Act. 2021;18(1):15–25.
 3. Contrepois K, Wu S, Moneghetti KJ, Hornburg D, Ahadi S, Tsai MS, et al. 
Molecular choreography of acute exercise. Cell. 2020;181(5):1112–1130.
e16.
 4. Sillanpää E, Ollikainen M, Kaprio J, Wang X, Leskinen T, Kujala UM, et al. 
Leisure-time physical activity and DNA methylation age-a twin study. Clin 
Epigenetics. 2019;11(1):12–5.
 5. Garatachea N, Lucia A. Genes, physical fitness and ageing. Ageing Res 
Rev. 2013;12(1):90–102.
 6. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hall-
marks of aging. Cell. 2013;153(6):1194–217.
 7. Horvath S. DNA methylation age of human tissues and cell types. 
Genome Biol. 2013;14(10):R115.
 8. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. 
Genome-wide methylation profiles reveal quantitative views of human 
aging rates. Mol Cell. 2013;49(2):359–67.
 9. Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An 
epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany 
NY). 2018;10(4):573–91.
 10. Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation 
GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 
2019;11(2):303–27.
 11. Chen BH, Marioni RE, Colicino E, Peters MJ, Ward-Caviness CK, Tsai PC, 
et al. DNA methylation-based measures of biological age: meta-analysis 
predicting time to death. Aging (Albany NY). 2016;8(9):1844–65.
 12. Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic 
clock theory of ageing. Nat Rev Genet. 2018;19(6):371–84.
 13. Horvath S, Mah V, Lu AT, Woo JS, Choi OW, Jasinska AJ, et al. The cerebel-
lum ages slowly according to the epigenetic clock. Aging (Albany NY). 
2015;7(5):294–306.
 14. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M, 
et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad 
Sci USA. 2014;111(43):15538–43.
 15. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, 
Schwartz AV, et al. Decreased muscle strength and quality in older 
adults with type 2 diabetes: the health, aging, and body composition 
study. Diabetes. 2006;55(6):1813–8.
 16. Volaklis KA, Halle M, Koenig W, Oberhoffer R, Grill E, Peters A, et al. Asso-
ciation between muscular strength and inflammatory markers among 
elderly persons with cardiac disease: results from the KORA-Age study. 
Clin Res Cardiol. 2015;104(11):982–9.
 17. Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predic-
tor of mortality: a narrative review. Eur J Intern Med. 2015;26(5):303–10.
 18. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al. 
Midlife hand grip strength as a predictor of old age disability. JAMA. 
1999;281(6):558–60.
 19. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle 
atrophy. Dis Model Mech. 2013;6(1):25–39.
 20. Sillanpää E, Laaksonen DE, Hakkinen A, Karavirta L, Jensen B, Kraemer 
WJ, et al. Body composition, fitness, and metabolic health during 
strength and endurance training and their combination in middle-
aged and older women. Eur J Appl Physiol. 2009;106(2):285–96.
 21. Sillanpää E, Hakkinen A, Nyman K, Mattila M, Cheng S, Karavirta L, et al. 
Body composition and fitness during strength and/or endurance train-
ing in older men. Med Sci Sports Exerc. 2008;40(5):950–8.
 22. Voisin S, Harvey NR, Haupt LM, Griffiths LR, Ashton KJ, Coffey VG, et al. 
An epigenetic clock for human skeletal muscle. J Cachexia Sarcopenia 
Muscle. 2020;11(4):887–98.
 23. Sillanpää E, Cheng S, Hakkinen K, Finni T, Walker S, Pesola A, et al. Body 
composition in 18- to 88-year-old adults–comparison of multifre-
quency bioimpedance and dual-energy X-ray absorptiometry. Obesity 
(Silver Spring). 2014;22(1):101–9.
 24. Christiansen L, Lenart A, Tan Q, Vaupel JW, Aviv A, McGue M, et al. DNA 
methylation age is associated with mortality in a longitudinal Danish 
twin study. Aging Cell. 2016;15(1):149–54.
 25. Alway SE, Myers MJ, Mohamed JS. Regulation of satellite cell function 
in sarcopenia. Front Aging Neurosci. 2014;6:246.
 26. Turner DC, Gorski PP, Maasar MF, Seaborne RA, Baumert P, Brown AD, 
et al. DNA methylation across the genome in aged human skeletal 
muscle tissue and muscle-derived cells: the role of HOX genes and 
physical activity. Sci Rep. 2020:10(1):15360.
 27. Henze H, Jung MJ, Ahrens HE, Steiner S, von Maltzahn J. Skeletal 
muscle aging—stem cells in the spotlight. Mech Ageing Dev. 
2020;189:111283.
 28. Li X, Li Z, Zhao M, Nie Y, Liu P, Zhu Y, et al. Skeletal muscle lipid droplets 
and the athlete’s paradox. Cells. 2019. https:// doi. org/ 10. 3390/ cells 
80302 49.
 29. Quach A, Levine ME, Tanaka T, Lu AT, Chen BH, Ferrucci L, et al. Epige-
netic clock analysis of diet, exercise, education, and lifestyle factors. 
Aging (Albany NY). 2017;9(2):419–46.
 30. Kankaanpää A, Tolvanen A, Bollepalli S, Leskinen T, Kujala UM, Kaprio J, 
et al. Leisure-time and occupational physical activity associates differ-
ently with epigenetic aging. Med Sci Sports Exerc. 2021;53(3):487–95.
 31. McCrory C, Fiorito G, Hernandez B, Polidoro S, O’Halloran AM, Hever A, 
et al. GrimAge outperforms other epigenetic clocks in the prediction 
of age-related clinical phenotypes and all-cause mortality. J Gerontol A 
Biol Sci Med Sci 2021;76(5):741–749.
 32. Kresovich Jacob K, Taylor JA, Sandler DP, White AJ, Xu Z, Niehoff NM, 
et al. Body composition and physical activity associations with multiple 
measures of epigenetic age acceleration. Am J Epidemiol. 2020. 
https:// doi. org/ 10. 1093/ aje/ kwaa2 51.
 33. Marioni RE, Shah S, McRae AF, Ritchie SJ, Muniz-Terrera G, Harris SE, et al. 
The epigenetic clock is correlated with physical and cognitive fitness in 
the Lothian Birth Cohort 1936. Int J Epidemiol. 2015;44(4):1388–96.
 34. Sillanpää E, Laakkonen EK, Vaara E, Rantanen T, Kovanen V, Sipilä S, et al. 
Biological clocks and physical functioning in monozygotic female twins. 
BMC Geriatr. 2018;18(1):83–6.
 35. Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah 
E, et al. Accelerated epigenetic aging in brain is associated with 
pre-mortem HIV-associated neurocognitive disorders. J Neurovirol. 
2016;22(3):366–75.
 36. Kaidesoja M, Aaltonen S, Bogl LH, Heikkila K, Kaartinen S, Kujala UM, et al. 
FinnTwin16: a longitudinal study from age 16 of a population-based Finn-
ish Twin Cohort. Twin Res Hum Genet. 2019;22(6):530–9.
 37. Rose RJ, Salvatore JE, Aaltonen S, Barr PB, Bogl LH, Byers HA, et al. 
FinnTwin12 Cohort: an updated review. Twin Res Hum Genet. 
2019;22(5):302–11.
 38. Kaprio J, Bollepalli S, Buchwald J, Iso-Markku P, Korhonen T, Kovanen V, 
et al. The older Finnish Twin Cohort—45 years of follow-up. Twin Res 
Hum Genet. 2019;22(4):240–54.
 39. Huang Y, Ollikainen M, Muniandy M, Zhang T, van Dongen J, Hao G, 
et al. Identification, heritability, and relation with gene expression 
of novel DNA methylation loci for blood pressure. Hypertension. 
2020;76(1):195–205.
 40. Naukkarinen J, Rissanen A, Kaprio J, Pietilainen KH. Causes and conse-
quences of obesity: the contribution of recent twin studies. Int J Obes 
(Lond). 2012;36(8):1017–24.
 41. Kovanen V, Aukee P, Kokko K, Finni T, Tarkka IM, Tammelin T, et al. Design 
and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study 
with 47 to 55-year-old women’s cohort: novel results show menopause-
related differences in blood count. Menopause. 2018;25(9):1020–32.
 42. Maksimovic J, Phipson B, Oshlack A. A cross-package bioconductor work-
flow for analysing methylation array data. F1000Res. 2016;5:1281.
 43. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-
Cabrero D, et al. A beta-mixture quantile normalization method for 
Page 15 of 15Sillanpää et al. Clin Epigenet          (2021) 13:110  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
correcting probe design bias in Illumina Infinium 450 k DNA methylation 
data. Bioinformatics. 2013;29(2):189–96.
 44. Fortin JP, Triche TJ, Hansen KD. Preprocessing, normalization and integra-
tion of the Illumina HumanMethylationEPIC array with minfi. Bioinformat-
ics. 2017;33(4):558–60.
 45. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measure-
ment of habitual physical activity in epidemiological studies. Am J Clin 
Nutr. 1982;36(5):936–42.
 46. Mustelin L, Latvala A, Pietilainen KH, Piirila P, Sovijarvi AR, Kujala UM, et al. 
Associations between sports participation, cardiorespiratory fitness, and 
adiposity in young adult twins. J Appl Physiol. 2011;110(3):681–6.
 47. Laakkonen EK, Kulmala J, Aukee P, Hakonen H, Kujala UM, Lowe DA, et al. 
Female reproductive factors are associated with objectively measured 
physical activity in middle-aged women. PLoS ONE. 2017;12(2):e0172054.
 48. Sasaki JE, John D, Freedson PS. Validation and comparison of ActiGraph 
activity monitors. J Sci Med Sport. 2011;14(5):411–6.
 49. Hyvarinen M, Sipila S, Kulmala J, Hakonen H, Tammelin TH, Kujala 
UM, et al. Validity and reliability of a single question for leisure-time 
physical activity assessment in middle-aged women. J Aging Phys Act. 
2019;28(2):231–41.
 50. Hirvensalo M, Lampinen P, Rantanen T. Physical exercise in old age: an 
eight-year follow-up study on involvement, motives, and obstacles 
among persons age 65–84. J Aging Phys Act. 1998;6:157–68.
 51. Mustelin L, Pietilainen KH, Rissanen A, Sovijarvi AR, Piirila P, Naukkarinen 
J, et al. Acquired obesity and poor physical fitness impair expression of 
genes of mitochondrial oxidative phosphorylation in monozygotic twins 
discordant for obesity. Am J Physiol Endocrinol Metab. 2008;295(1):148.
 52. Enright PL. The six-minute walk test. Respir Care. 2003;48(8):783–5.
 53. Ronkainen PH, Kovanen V, Alen M, Pollanen E, Palonen EM, Ankarberg-
Lindgren C, et al. Postmenopausal hormone replacement therapy 
modifies skeletal muscle composition and function: a study with 
monozygotic twin pairs. J Appl Physiol. 2009;107(1):25–33.
 54. Rantanen T, Era P, Heikkinen E. Maximal isometric strength and mobility 
among 75-year-old men and women. Age Ageing. 1994;23(2):132–7.
 55. Bondarev D, Finni T, Kokko K, Kujala UM, Aukee P, Kovanen V, et al. Physical 
performance during the menopausal transition and the role of physical 
activity. J Gerontol A Biol Sci Med Sci. 2020;. https:// doi. org/ 10. 1093/ 
gerona/ glaa2 92.
 56. Bosco C, Luhtanen P, Komi PV. A simple method for measurement 
of mechanical power in jumping. Eur J Appl Physiol Occup Physiol. 
1983;50(2):273–82.
 57. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. 
A comparison of leg power and leg strength within the InCHIANTI 
study: which influences mobility more? J Gerontol A Biol Sci Med Sci. 
2003;58(8):728–33.
 58. Runge M, Rittweger J, Russo CR, Schiessl H, Felsenberg D. Is muscle 
power output a key factor in the age-related decline in physical per-
formance? A comparison of muscle cross section, chair-rising test and 
jumping power. Clin Physiol Funct Imaging. 2004;24(6):335–40.
 59. Sipilä P, Rose RJ, Kaprio J. Drinking and mortality: long-term follow-up of 
drinking-discordant twin pairs. Addiction. 2016;111(2):245–54.
 60. Stephenson M, Bollepalli S, Cazaly E, Salvatore JE, Barr P, Rose RJ, et al. 
Associations of alcohol consumption with epigenome-wide DNA meth-
ylation and epigenetic age acceleration: individual-level and co-twin 
comparison analyses. Alcohol Clin Exp Res. 2020;45(2):318–28.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
